India’s information technology and pharma stocks are among those that investors will be watching closely as they await the outcome of next week’s US presidential election.
Drugmakers and software exporters are the top performers in India’s $2.1 trillion equity market this year amid the pandemic. The result of the Nov. 3 vote could have a bearing on these companies through taxation, trade and immigration policies, and currency movements. More broadly, India is seen emerging as one of the biggest beneficiaries in Asia Pacific from the election, irrespective of the outcome, according to UBS Group AG.
A UBS analysis of the